H. Nasrallah
Psychiatry and Mental health · 2005–2009
A researcher in the Science corpus: 2 papers; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Psychiatry and Mental health — 25 citations into it
Whom H. Nasrallah trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from H. Nasrallah's perspective
Ordered by how strongly the researchers H. Nasrallah trusts endorse each paper. Same corpus, a different order for every researcher.
- The endophenotype concept in psychiatry: etymology and strategic intentions. (American Journal of Psychiatry)
- Remission in schizophrenia: proposed criteria and rationale for consensus. (American Journal of Psychiatry)
- The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. (Archives of Internal Medicine)
- A comparison of the prevalence of the metabolic syndrome using two proposed definitions. (Diabetes Care)
- Physical illness and schizophrenia: a review of the literature (Acta Psychiatrica Scandinavica)
- Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
- Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. (Schizophrenia bulletin)
- Recovery from psychotic illness: A 15- and 25-year international follow-up study (British Journal of Psychiatry)
- Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. (American Journal of Psychiatry)
- Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). (Archives of General Psychiatry)
Their papers
- Schizophrenia, "just the facts" 4. Clinical features and conceptualization. (2009) — 1,016 citations
- Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. (2005) — 1,208 citations